TY - JOUR
T1 - Breast-Contour-Preserving Procedure as a Multidisciplinary Parameter of Esthetic Outcome in Breast Cancer Treatment in The Netherlands
AU - van Bommel, Annnelotte
AU - Spronk, Pauline
AU - Mureau, Marc
AU - Siesling, Sabine
AU - Smorenburg, Carolien
AU - Tollenaar, Rob
AU - Vrancken Peeters, Marie-Jeanne
AU - van Dalen, Thijs
N1 - Funding Information:
The authors would like to thank all surgeons, registrars, physician assistants, administrative nurses, and registrars of the Netherlands Comprehensive Cancer Organisation (IKNL) that registered all the patients in the NBCA, as well as the NABON Breast Cancer Audit Working Group. This research received no specific funding.
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/6
Y1 - 2019/6
N2 - BACKGROUND: The rate of breast-conserving surgery (BCS) is used as an esthetic outcome parameter, while other treatments contribute also, such as neoadjuvant chemotherapy (NAC) enabling BCS or immediate breast reconstruction (IBR). This study explores these efforts to preserve the patient's breast contour.PATIENTS AND METHODS: All patients who underwent surgery for invasive breast cancer in The Netherlands between January 2011 and December 2015 were selected from the Dutch national breast cancer audit (n = 61,309). The breast-contour-preserving procedures (BCPP) rate was defined as the rate of primary BCS, BCS after NAC, or mastectomy with IBR. BCPP rates were calculated and compared by year of diagnosis, age categories, and individual hospitals.RESULTS: The rate of primary BCS remained stable (53%) while the BCPP rate increased from 63% in 2011 to 71% in 2015 due to an increase in patients receiving BCS after NAC and mastectomy with IBR. Primary BCS rates increased with age (from 17% in patients aged < 30 years to 63% in patients aged 60-69 years), while the proportion of patients undergoing mastectomy with IBR decreased from 44% in patients < 30 years to 1% in patients ≥ 70 years. The BCPP rate was similar for all age groups except for patients > 70 years. BCPP rates varied between the different hospitals in The Netherlands, ranging from 47 to 88%.CONCLUSIONS: The chance of preserving the breast contour for patients with breast cancer has increased substantially over recent years. BCPP provides a comprehensive parameter of esthetic outcome of breast cancer surgery.
AB - BACKGROUND: The rate of breast-conserving surgery (BCS) is used as an esthetic outcome parameter, while other treatments contribute also, such as neoadjuvant chemotherapy (NAC) enabling BCS or immediate breast reconstruction (IBR). This study explores these efforts to preserve the patient's breast contour.PATIENTS AND METHODS: All patients who underwent surgery for invasive breast cancer in The Netherlands between January 2011 and December 2015 were selected from the Dutch national breast cancer audit (n = 61,309). The breast-contour-preserving procedures (BCPP) rate was defined as the rate of primary BCS, BCS after NAC, or mastectomy with IBR. BCPP rates were calculated and compared by year of diagnosis, age categories, and individual hospitals.RESULTS: The rate of primary BCS remained stable (53%) while the BCPP rate increased from 63% in 2011 to 71% in 2015 due to an increase in patients receiving BCS after NAC and mastectomy with IBR. Primary BCS rates increased with age (from 17% in patients aged < 30 years to 63% in patients aged 60-69 years), while the proportion of patients undergoing mastectomy with IBR decreased from 44% in patients < 30 years to 1% in patients ≥ 70 years. The BCPP rate was similar for all age groups except for patients > 70 years. BCPP rates varied between the different hospitals in The Netherlands, ranging from 47 to 88%.CONCLUSIONS: The chance of preserving the breast contour for patients with breast cancer has increased substantially over recent years. BCPP provides a comprehensive parameter of esthetic outcome of breast cancer surgery.
KW - Adult
KW - Aged
KW - Breast Neoplasms/pathology
KW - Carcinoma, Ductal, Breast/pathology
KW - Carcinoma, Lobular/pathology
KW - Chemotherapy, Adjuvant
KW - Esthetics
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Mammaplasty
KW - Mastectomy, Segmental
KW - Middle Aged
KW - Neoadjuvant Therapy
KW - Neoplasm Invasiveness
KW - Netherlands
KW - Organ Sparing Treatments/methods
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=85062732825&partnerID=8YFLogxK
U2 - 10.1245/s10434-019-07265-3
DO - 10.1245/s10434-019-07265-3
M3 - Article
C2 - 30830541
SN - 1068-9265
VL - 26
SP - 1704
EP - 1711
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 6
ER -